Table 3. Characteristics of patients with sentinel lymph node metastasis.
| No. | Age | Histology | Pre-operative grade | Post-operative grade | Myometrial invasion | SLN | LND in algorithm steps | Other LNM sites |
|---|---|---|---|---|---|---|---|---|
| 1 | 47 | Endometrioid | 1 | 2 | >50% | Isole Tumor cell | Bilateral Pelvic | None |
| 2 | 54 | Endometrioid | 2 | 2 | <50% | Micrometastasis | Bilateral Pelvic | None |
| 3 | 59 | Endometrioid | 2 | 3 | >50% | Micrometastasis | Bilateral Pelvic + Paraaortic | Pelvic 3/14 positive |
| 4 | 49 | Endometrioid | 2 | 3 | >50% | Micrometastasis | Bilateral Pelvic+ Paraaortic | Pelvic 1/12 positive |
| 5 | 62 | Endometrioid | 2 | 3 | >50% | Micrometastasis | Bilateral Pelvic+ Paraaortic | Pelvic 2/11, paraaortic 2/14 positive |
| 6 | 58 | Endometrioid | 3 | 3 | >50% | Micrometastasis | Bilateral Pelvic+ Paraaortic | Pelvic 3/11, positive |
| 7 | 65 | Endometrioid | 3 | 3 | >50% | Macrometastasis | Bilateral Pelvic+ Paraaortic | Pelvic 3/16, paraaortic 1/7 positive |
| 8 | 49 | Endometrioid | 3 | 3 | >50% | Macrometastasis | Bilateral Pelvic+ Paraaortic | Pelvic 1/8 positive |
| 9 | 67 | Endometrioid | 3 | 3 | >50% | Macrometastasis | Bilateral Pelvic+ Paraaortic | Pelvic 3/11 positive |
| 10 | 65 | Serous | 3 | 3 | >50% | Macrometastasis | Bilateral Pelvic+ Paraaortic | Pelvic 3/15, paraaortic 1/9 positive |
| 11 | 58 | Serous | 3 | 3 | >50% | Macrometastasis | Bilateral Pelvic+ Paraaortic | Pelvic 2/9 positive |
| 12 | 62 | Serous | 3 | 3 | <50% | Micrometastasis | Bilateral Pelvic+ Paraaortic | Pelvic 3/14 positive |
| 13 | 55 | Clear cell | 3 | 3 | <50% | Macrometastasis | Bilateral Pelvic+ Paraaortic | Pelvic 2/11 positive |
| 14 | 65 | Clear cell | 3 | 3 | >50% | Macrometastasis | Bilateral Pelvic+ Paraaortic | Pelvic 2/10 positive |
| 15 | 56 | Endometrioid | 3 | 3 | >50% | None | Bilateral Pelvic+ Paraaortic | Paraaortic 2/8 positive |
Note: SLN: sentinel lymph node; LND: lymph node dissection; LNM: lymph node metastasis.